Tumor response assessment by measuring the single largest lesion per organ in advanced non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitor

Background: For Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST1.1), measuring up to two target lesions per organ is an arbitrary criterion. Objectives: We sought to compare response assessment using RECIST1.1 and modified RECIST1.1 (mRECIST1.1, measuring the single largest lesion p...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Li-Na He, Tao Chen, Sha Fu, Yongluo Jiang, Xuanye Zhang, Chen Chen, Wei Du, Linfeng Luo, Anlin Li, Yixing Wang, Hui Yu, Yixin Zhou, Yuhong Wang, Yunpeng Yang, Yan Huang, Hongyun Zhao, Wenfeng Fang, Li Zhang, Shaodong Hong
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	SAGE Publishing 2023-10-01
Reeks:	Therapeutic Advances in Medical Oncology
Online toegang:	https://doi.org/10.1177/17588359231200463
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!